{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T19:19:28Z","timestamp":1785611968840,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/51\/B\/NZ7\/00537"],"award-info":[{"award-number":["2023\/51\/B\/NZ7\/00537"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.aca.2026.345445","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:01:12Z","timestamp":1774512072000},"page":"345445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic oligonucleotide (nusinersen) metabolism in cerebrospinal fluid samples of patients with spinal muscular atrophy based on liquid chromatography coupled with mass spectrometry data"],"prefix":"10.1016","volume":"1404","author":[{"given":"Sylwia","family":"Studzi\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lemska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Szymarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazurkiewicz-Be\u0142dzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2026.345445_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jcph.884","article-title":"Population pharmacokinetics of nusinersen in the cerebral spinal fluid and plasma of pediatric patients with spinal muscular atrophy following intrathecal administrations","volume":"57","author":"Luu","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.aca.2026.345445_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.prerep.2025.100031","article-title":"Spinal Muscular Atrophy (SMA): treatment strategies, challenges and future prospects","volume":"3","author":"Mishra","year":"2025","journal-title":"Pharmacological Research - Reports"},{"key":"10.1016\/j.aca.2026.345445_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/17576180.2025.2535949","article-title":"LC-MS\/MS quantification of nusinersen in rat cerebrospinal fluid and preclinical pharmacokinetics study application","volume":"17","author":"Li","year":"2025","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345445_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4155\/bio-2023-0218","article-title":"Development, validation and application of an ion-pair reversed-phase liquid chromatography-tandem mass spectrometry method for the quantification of nusinersen","volume":"16","author":"Zhang","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345445_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.70138","article-title":"Development and validation of an LC\u2013MS\/MS assay for quantitative analysis of nusinersen in human CSF and plasma","volume":"39","author":"Xu","year":"2025","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.aca.2026.345445_bib6","first-page":"194","article-title":"Nusinersen: a novel antisense oligonucleotide for the treatment of spinal muscular atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"key":"10.1016\/j.aca.2026.345445_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710166","article-title":"Development of the method for Nusinersen and its metabolites identification in the serum samples of children treated with spinraza for spinal muscular atrophy","volume":"23","author":"Studzi\u0144ska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.aca.2026.345445_bib8","article-title":"Development and validation of an HILIC\/MS\/MS method for determination of nusinersen in rabbit plasma","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.aca.2026.345445_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2017.08.025","article-title":"Review on investigations of antisense oligonucleotides with the use of mass spectrometry","volume":"176","author":"Studzi\u0144ska","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.aca.2026.345445_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/10408347.2018.1517034","article-title":"Analysis of antisense oligonucleotides and their metabolites with the use of ion pair reversed-phase liquid chromatography coupled with mass spectrometry","volume":"49","author":"Kaczmarkiewicz","year":"2019","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.aca.2026.345445_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340994","article-title":"Managing nonspecific adsorption to liquid chromatography hardware: a review","volume":"1250","author":"Guimaraes","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.aca.2026.345445_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.14953","article-title":"Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy","volume":"153","author":"Kessler","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.aca.2026.345445_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126153","article-title":"A sensitive analytical strategy of oligonucleotide functionalized fluorescent probes for detection of nusinersen sodium in human serum","volume":"275","author":"Zhan","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.aca.2026.345445_bib14","doi-asserted-by":"crossref","DOI":"10.1039\/D4AN00436A","article-title":"Study of nusinersen metabolites in the cerebrospinal fluid of children with spinal muscular atrophy using ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry","volume":"149","author":"Studzi\u0144ska","year":"2024","journal-title":"Analyst"},{"key":"10.1016\/j.aca.2026.345445_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125173","article-title":"Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy","volume":"267","author":"Studzi\u0144ska","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.aca.2026.345445_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s13062-023-00413-6","article-title":"Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen","volume":"18","author":"Garofalo","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.aca.2026.345445_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/mus.27731","article-title":"Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy","volume":"66","author":"Orbach","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.aca.2026.345445_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-12984-7","article-title":"Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen","volume":"272","author":"Cebulla","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.aca.2026.345445_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-025-08267-8","article-title":"Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients","volume":"46","author":"Li","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.aca.2026.345445_bib20","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4155\/bio-2018-0166","article-title":"Development of SPE method for the extraction of phosphorothioate oligonucleotides from serum samples","volume":"10","author":"Nuckowski","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345445_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jchromb.2005.09.036","article-title":"Determination of GTI-2040, a novel antisense oligonucleotide, in human plasma by using HPLC combined with solid phase and liquid\u2013liquid extractions","volume":"829","author":"Zhang","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345445_bib22","unstructured":"https:\/\/numiqo.com\/statistics-calculator\/design-of-experiments, (n.d.)."},{"key":"10.1016\/j.aca.2026.345445_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114439","article-title":"Impact of nonspecific adsorption to metal surfaces in ion Pair-RP LC-MS impurity analysis of oligonucleotides","volume":"208","author":"Guimaraes","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345445_bib24","first-page":"1677","article-title":"The impact of low adsorption surfaces for the analysis of DNA and RNA oligonucleotides","volume":"A","author":"Lardeux","year":"2022","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.aca.2026.345445_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4155\/bio-2021-0115","article-title":"Assessing the impact of nonspecific binding on oligonucleotide bioanalysis","volume":"13","author":"Nguyen","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345445_bib26","author":"Lardeux"},{"key":"10.1016\/j.aca.2026.345445_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/jasms.0c00380","article-title":"Oligonucleotide anion adduct Formation using negative ion electrospray ion-mobility mass spectrometry","volume":"32","author":"Sutton","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2019.07.006","article-title":"Metabolite profiling of the antisense Oligonucleotide Eluforsen using liquid chromatography-mass spectrometry","volume":"17","author":"Kim","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.aca.2026.345445_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13361-012-0509-5","article-title":"The effect of organic modifiers on electrospray ionization charge-state distribution and desorption efficiency for oligonucleotides","volume":"24","author":"Chen","year":"2013","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-020-02878-0","article-title":"Studying in vitro metabolism of the first and second generation of antisense oligonucleotides with the use of ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry","volume":"412","author":"Kilanowska","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.aca.2026.345445_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.talanta.2018.12.023","article-title":"Analysis of the first and second generation of antisense oligonucleotides in serum samples with the use of ultra high performance liquid chromatography coupled with tandem mass spectrometry","volume":"196","author":"Kaczmarkiewicz","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.aca.2026.345445_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/rcm.959","article-title":"Analysis of native and chemically modified oligonucleotides by tandem ion\u2010pair reversed\u2010phase high\u2010performance liquid chromatography\/electrospray ionization mass spectrometry","volume":"17","author":"Fountain","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/154545703322460612","article-title":"Characterization of therapeutic oligonucleotides using liquid chromatography with On-line mass spectrometry detection","volume":"13","author":"Gilar","year":"2003","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.aca.2026.345445_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4839","article-title":"In vitro metabolism of 2\u2032\u2010ribose unmodified and modified phosphorothioate oligonucleotide therapeutics using liquid chromatography mass spectrometry","volume":"34","author":"Kim","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.aca.2026.345445_bib35","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/rcm.6733","article-title":"Systematic optimization of ion\u2010pairing agents and hexafluoroisopropanol for enhanced electrospray ionization mass spectrometry of oligonucleotides","volume":"27","author":"McGinnis","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/rcm.6773","article-title":"Comparing ion\u2010pairing reagents and sample dissolution solvents for ion\u2010pairing reversed\u2010phase liquid chromatography\/electrospray ionization mass spectrometry analysis of oligonucleotides","volume":"28","author":"Gong","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s13361-016-1500-3","article-title":"The role of fluorinated alcohols as Mobile phase modifiers for LC-MS analysis of oligonucleotides","volume":"28","author":"Basiri","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ab.2009.03.042","article-title":"Reversed-phase ion-pair liquid chromatography analysis and purification of small interfering RNA","volume":"390","author":"McCarthy","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.aca.2026.345445_bib39","doi-asserted-by":"crossref","DOI":"10.4155\/bio.14.94","article-title":"LC-MS of oligonucleotides: applications in biomedical research","volume":"6","author":"Basiri","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345445_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.chroma.2018.10.040","article-title":"Alkylamine ion-pairing reagents and the chromatographic separation of oligonucleotides","volume":"1580","author":"Li","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2026.345445_bib41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s13361-017-1671-6","article-title":"Assessing the interplay between the physicochemical parameters of ion-pairing reagents and the analyte sequence on the electrospray desorption process for oligonucleotides","volume":"28","author":"Basiri","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345445_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpba.2012.06.022","article-title":"Development and validation of LC\u2013MS\/MS method for the detection and quantification of CpG oligonucleotides 107 (CpG ODN107) and its metabolites in mice plasma","volume":"70","author":"Cen","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345445_bib43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1208\/s12248-012-9381-2","article-title":"Phosphorothioate oligonucleotide quantification by \u03bc-Liquid chromatography-mass spectrometry","volume":"14","author":"Erb","year":"2012","journal-title":"AAPS J."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026003958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026003958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:20:34Z","timestamp":1778934034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267026003958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0003267026003958"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2026.345445","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic oligonucleotide (nusinersen) metabolism in cerebrospinal fluid samples of patients with spinal muscular atrophy based on liquid chromatography coupled with mass spectrometry data","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2026.345445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"345445"}}